Navigation Links
Bionovo Appoints Dr. Klaus Kohl as Chief Technical Officer
Date:6/2/2009

EMERYVILLE, Calif., June 2 /PRNewswire-FirstCall/ -- Bionovo Inc. (Nasdaq: BNVI) announced today the appointment of Klaus Kohl, Ph.D., as Senior Vice President and Chief Technical Officer. Dr. Kohl brings to Bionovo over 20 years of experience in product development and manufacturing. Dr. Kohl will be responsible for manufacturing, quality assurance, and regulatory compliance.

"We are very excited to add Dr. Kohl to our management team," said Isaac Cohen, O.M.D., Bionovo's Chairman and CEO. He added, "We believe Dr. Kohl's extensive background in the pharmaceutical industry will prove invaluable to Bionovo's current efforts. Klaus' two decades of experience and broad knowledge will optimize our organization to meet with partnering and commercialization standards."

Dr. Kohl's most recent position was as Vice President of Program Management, CMC and Regulatory Affairs at Novo Nordisk Delivery Technologies, where he was responsible for the development of an inhaled insulin drug/device combination product. Prior to Novo Nordisk, Dr. Kohl served as Senior Vice President, Quality and Technical Director at Aradigm Corporation, a specialty pharmaceutical development company focused on respiratory disease management.

From 1985 to 2001, Dr. Kohl worked for Bayer Corporation, where he held various executive positions in quality assurance and drug product development. Before Bayer, Dr. Kohl was engaged in basic research for more than seven years at the Juelich Research Center in Germany, and the Max Planck Institute in Dortmund, Germany.

Dr. Kohl holds an undergraduate degree in Mathematics and Physics from the University of Marburg, Germany, and a master's degree in Experimental Physics and Ph.D. in Biophysics from the University of Aachen, Germany.

Dr. Kohl states, "I feel I am joining
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Bionovo Announces Publication of Data on Active Compound and Mechanism of Action for Its Preclinical Cancer Treatment, BN108
2. Bionovo Announces 2008 Highlights and Year-End Financial Results
3. Bionovo Announces Publication of Positive Phase 2 Trial Results for Menerba(TM)
4. Bert W. OMalley, M.D., Recipient of the 2008 National Medal for Science, Joins Bionovos Scientific Advisory Board
5. Bionovo Publishes Discoveries in Predictable Tissue Selectivity for Selective Estrogen Receptor Modulators Platform
6. Bionovo to Present Recent Findings of BN107, its Anticancer Agent, at the 31st Annual San Antonio Breast Cancer Symposium
7. Bionovo to Present at the Piper Jaffray Healthcare Conference
8. Ethan Weiss, M.D., Joins Bionovos Scientific Advisory Board
9. Bionovo Reports Third Quarter 2008 Financial Results
10. Bionovo to Present at Merriman Curhan Fords Investor Summit 2008 on September 15th
11. Bionovo to Present at Canaccord Adams Global Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... Sept. 19, 2014  An entire month is dedicated ... neuropathies – Charcot-Marie-Tooth disease (CMT) – a debilitating neuromuscular ... extreme muscle atrophy, weakness, and foot and hand deformities. ... millions worldwide. CMT is a progressive disease, and over ... requiring mobility devices such as leg braces, wheelchairs and ...
(Date:9/19/2014)... CORAL SPRINGS, Florida , September 19, 2014 /PRNewswire/ ... biotech companies release latest developments, patents and results of ... (OTC: GNSZ), Eli Lilly and Company (NYSE: ... ), Celgene Corporation (NASDAQ: CELG ) and ... (OTCQB: GNSZ), a leader in developing prodrug therapeutics for ...
(Date:9/19/2014)... ROCKLAND, Massachusetts , September 19, 2014 ... with the 53rd European Society for Paediatric Endocrinology (ESPE) ... advancement of science and medical research in the field ... of Merck KGaA, Darmstadt, Germany , ... Growth Innovation (GGI) for 2014. The awards were announced ...
(Date:9/18/2014)... -- About POCT POCT, also ... laboratory. It helps in making fast clinical decisions, ... POCT is gaining popularity due to the increasing ... diabetes, heart disease, and obesity. It is generally ... minimize errors during the diagnosis of patients. POCT ...
Breaking Biology Technology:September is Charcot-Marie-Tooth (CMT) Awareness Month - Scheduled events, activities and important partnerships announced throughout the month! 2Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 2Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 3Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 4Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 5Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 6Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 7EMD Serono Awards Grant for Growth Innovation (GGI) for the First Time 2EMD Serono Awards Grant for Growth Innovation (GGI) for the First Time 3POCT Market in China 2014-2018 2
... After receiving FDA clearance for two new brain imaging ... to market its products to healthcare providers. , ,Approval ... for Devices and Radiologic Health in June allowed ... products to its line of brain mapping solutions based ...
... Healthcare has received permission to continue trading company stock ... listing standards. , ,Merge, a developer of medical imaging and ... will allow it to continue listing its common stock subject ... 29, 2006. The company was unable to comply with filing ...
... is a world-class company and object of emulation for many. ... true conglomerate, but one that is more than an investment ... from aircraft engines and massive power-generating turbines to financial services ... GE is knowledge intensive in all its businesses and global ...
Cached Biology Technology:Kyron wins FDA approval for brain imaging technology 2Growth through the eyes of GE's Immelt 2Growth through the eyes of GE's Immelt 3Growth through the eyes of GE's Immelt 4Growth through the eyes of GE's Immelt 5
(Date:9/18/2014)... its newborn screening program into a model other states can ... first-ever Newborn Screening Quality Award from the March of Dimes. ... Arizona,s Department of Health Services director, with the award at ... of full transparency for the length of time it takes ... for analysis, and set a target of having 95 percent ...
(Date:9/18/2014)... several disciplines will be celebrated tonight at the third ... improving the health of premature infants and in paving ... researchers, whose work was supported by the National Science ... Atomic Energy Commission, will be honored at a ceremony ... bipartisan group of Members of Congress will be on ...
(Date:9/18/2014)... 18, 2014 Elsevier, a world-leading provider of ... and the Australasian Research Management Society (ARMS), recognized ... at the 5th Scopus Young Researcher of the ... today at the National Convention Centre and in ... attended by guests representing Australia,s and New Zealand,s ...
Breaking Biology News(10 mins):March of Dimes honors Arizona with first-ever newborn screening award 2March of Dimes honors Arizona with first-ever newborn screening award 33rd annual Golden Goose award ceremony honors 8 researchers; Unusual work had big results 2Elsevier and Australasian Research Management Society award scientists at Scopus ceremony 2
... Jerrold Meyer and colleagues at the University of Massachusetts ... as an important new biomarker for stress in wild ... demonstrated in the current issue of the Journal ... lab manager Kendra Rosenberg and neuroscience and behavior graduate ...
... 2014) Researchers from Massachusetts Eye and Ear, ... Massachusetts General Hospital have demonstrated, for the first ... of vestibular schwannomas (also known as acoustic neuromas), ... hearing loss and tinnitus. Motivated by ...
... and why now? , Islands are renowned for their ... biogeography, and ecology. As a result of the devastating ... and island conservation has become a vital international concern. ... islands at an unprecedented pace, and now is an ...
Cached Biology News:Biomarker for stress hormones in polar bears, wildlife affected by global climate change 2Aspirin intake may stop growth of vestibular schwannomas/acoustic neuromas 2Island Biology 2014: An International Conference on Island Evolution, Ecology, and Conservation 2
... Immunogen: KLH-conjugated, synthetic peptide ... which [ Ac K] corresponds to acetyl ... Accession Number: NM_003493 ... Quality Assurance: Routinely ...
synaptotagmin XIV-like [Source:RefSeq_peptide;Acc:NP_114120] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Naked1 Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Rabbit polyclonal to IRS1 (phospho S636) ( Abpromise for all tested applications). entrezGeneID: 3667 SwissProtID: P35568...
Biology Products: